Here are the key things you need to know about in the NZX markets over the past 24 hours. Changes are as at 3:00 pm and may change when the market closes at 4:45 pm.
WHAT THE NZX 50 INDEX IS DOING
The NZX50 edges lower, currently declining -0.3%, although the index is up +0.4% over the past five trading sessions and +6.5% ahead over the last 12 months.
THE MAIN GAINERS
A total of 45 stocks finished higher during the session, led by Gentrack Group (GTK, #47), which climbed +4% on the day, extending its five-day gain to +14%. Despite the rally, the stock is -32% lower over one month, -60% lower over six months and -66% behind its level a year ago. Sanford (SAN, #37) advanced +2%, adding to a +2% gain over the past week while improving to +3% over six months and +39% over the past year. Investore Property (IPL, #48) gained +2% for the day and +3% over five days, although the stock remained -3% lower over one month, -14% lower over six months and -7% down year-on-year. Hallenstein Glassons (HLG, #41) also rose +2%, building on a +1% five-day gain, while remaining +3% higher over six months and +28% ahead over the last 12 months.
Gentrack
Select chart tabs
THE MAIN DECLINERS
A total of 35 stocks closed lower, with Vista Group (VGL, #40) leading the declines after falling -3%. The stock moved -10% lower over five days and -13% lower over six months, despite remaining +24% higher over one month. Ebos Group (EBO, #12) also dropped -3%, extending declines to -2% over five days, -10% over one month, -33% over six months and -50% over the past year. Mainfreight (MFT, #7) eased -2% on the day, though it retained gains of +2% over five days and +4% over one month, while remaining -5% lower over six months and -6% lower year-on-year. A2 Milk (ATM, #10) slipped -1%, adding to a -18% one-month decline and a -39% six-month retreat, leaving the stock -21% lower than a year ago.
Vista Group
Select chart tabs
SMARTSHARES EFTs
| 1-day | 5-day | 6-month | YTD | 1Y | |
| NZ Top 50 ETF (FNZ) | +0.2% | +0.4% | -6.2% | -6.7% | +3.8% |
| NZ Top 10 ETF (TNZ) | +0.1% | -0.5% | -3.2% | -3.2% | +1.9% |
| S/P NZX50 ETF (NZG) | +0.1% | -0.6% | -4.1% | -4.1% | +3.8% |
| NZ Dividend ETF (DIV) | +0.8% | +1.2% | +0.2% | -1.4% | +16.7% |
KEY ANNOUNCEMENTS
Ryman Healthcare (RYM, #18) advised it is considering an offer of new six-year fixed-rate secured bonds, providing investors with a potential new income investment option while strengthening the company's funding profile. The proposed bonds would be guaranteed by the Ryman guaranteeing group and rank as secured, unsubordinated debt. Ryman also outlined a potential exchange mechanism allowing eligible holders of existing RYM010 bonds held through custodial accounts to swap into the new bonds on a one-for-one basis, while appointing ANZ, Craigs Investment Partners, Forsyth Barr and Westpac as lead managers for the offer. Full details are expected to be released early June.
Scales Corp (SCL, #33) has declared a final cash dividend for FY2025 of 12.5 cents per share (partially imputed at 50%), payable on the 9th of July. Combined with the interim dividend paid earlier in January, this brings the company's total cash dividends for the FY2025 financial year to 25.0 cents per share, representing a payout of 59% of its Underlying Net Profit Attributable to Shareholders.
Pacific Edge (PEB) has completed a NZ$36.1 mln capital raising at NZ$0.17 per share, comprising a NZ$25.4 mln placement and a NZ$10.7 mln retail offer that was significantly oversubscribed with NZ$46.0 mln in applications, resulting in additional oversubscriptions being accepted at the company’s discretion. A total of 62,703,746 new shares will be issued, with most eligible shareholders receiving allocations broadly maintaining their relative holdings. The funds will support Pacific Edge’s growth strategy for its Cxbladder diagnostics business, with shares expected to be issued and commence trading on the NZX on the 4th of June.
NZX50 Healthcare Sector
Select chart tabs
Click on the chart title to find more about this sector, including its components.
We welcome your comments below. If you are not already registered, please register to comment
Remember we welcome robust, respectful and insightful debate. We don't welcome abusive or defamatory comments and will de-register those repeatedly making such comments. Our current comment policy is here.